Similar articles for PMID: 22673025

Year	Number of Results
1930	1
2001	1
2003	2
2004	7
2005	10
2006	8
2007	1
2008	4
2009	10
2010	6
2011	6
2012	4
2013	3
2014	7
2015	1
2016	2
2017	2
2018	3
2019	1
2020	2
2021	2
2023	1
2024	0

1

The growing importance of PON1 in cardiovascular health: a review.

Macharia M, Hassan MS, Blackhurst D, Erasmus RT, Matsha TE. Macharia M, et al. J Cardiovasc Med (Hagerstown). 2012 Jul;13(7):443-53. doi: 10.2459/JCM.0b013e328354e3ac. J Cardiovasc Med (Hagerstown). 2012. PMID: 22673025 Review.

2

The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.

van Himbergen TM, van Tits LJ, Roest M, Stalenhoef AF. van Himbergen TM, et al. Neth J Med. 2006 Feb;64(2):34-8. Neth J Med. 2006. PMID: 16517986 Free article. Review.

3

The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.

Otocka-Kmiecik A, Orłowska-Majdak M. Otocka-Kmiecik A, et al. Postepy Hig Med Dosw (Online). 2009 Dec 30;63:668-77. Postepy Hig Med Dosw (Online). 2009. PMID: 20097953 Free article. Review.

4

Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.

Connelly PW, Draganov D, Maguire GF. Connelly PW, et al. Free Radic Biol Med. 2005 Jan 15;38(2):164-74. doi: 10.1016/j.freeradbiomed.2004.10.010. Free Radic Biol Med. 2005. PMID: 15607900 Review.

5

[Paraoxonase: its multiple functions and pharmacological regulation].

Fridman O, Fuchs AG, Porcile R, Morales AV, Gariglio LO. Fridman O, et al. Arch Cardiol Mex. 2011 Jul-Sep;81(3):251-60. Arch Cardiol Mex. 2011. PMID: 21975240 Review. Spanish.

6

Pharmacogenetics of paraoxonases: a brief review.

Draganov DI, La Du BN. Draganov DI, et al. Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):78-88. doi: 10.1007/s00210-003-0833-1. Epub 2003 Oct 25. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14579013 Free article. Review.

7

Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases.

Androutsopoulos VP, Kanavouras K, Tsatsakis AM. Androutsopoulos VP, et al. Toxicol Appl Pharmacol. 2011 Nov 1;256(3):418-24. doi: 10.1016/j.taap.2011.08.009. Epub 2011 Aug 12. Toxicol Appl Pharmacol. 2011. PMID: 21864557 Review.

8

The paraoxonase gene family and atherosclerosis.

Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. Ng CJ, et al. Free Radic Biol Med. 2005 Jan 15;38(2):153-63. doi: 10.1016/j.freeradbiomed.2004.09.035. Free Radic Biol Med. 2005. PMID: 15607899 Review.

9

Paraoxonases role in the prevention of cardiovascular diseases.

Rosenblat M, Aviram M. Rosenblat M, et al. Biofactors. 2009 Jan-Feb;35(1):98-104. doi: 10.1002/biof.16. Biofactors. 2009. PMID: 19319852 Review.

10

Variation in paraoxonase-1 activity and atherosclerosis.

Soran H, Younis NN, Charlton-Menys V, Durrington P. Soran H, et al. Curr Opin Lipidol. 2009 Aug;20(4):265-74. doi: 10.1097/MOL.0b013e32832ec141. Curr Opin Lipidol. 2009. PMID: 19550323 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year